Electromyography in Patients on Chronic Pyridostigmine Therapy
Completed · Not applicable
Conditions studied: Muscle Weakness
In brief
We intend to measure evoked EMG at two sites in subjects who are chronically taking pyridostigmine.
Key facts
- Study ID
- NCT02364180
- Run by
- University of Toledo Health Science Campus
- People needed
- 11
- Starts
- 2013-12-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2017-05-09
Who can join
Age: 12 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who have been taking pyridostigmine for the treatment of any condition other than myasthenia gravis
You may not qualify if…
- Subjects taking pyridostigmine for the treatment of myasthenia gravis will be excluded.
Where it is running
- University of Toledo, Health Science Campus — Toledo, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.